Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 1273 Specimen Handling 871 Carboplatin 832 Magnetic Resonance Spectroscopy 808 Cyclophosphamide 803 Cisplatin 729 Nivolumab 659 Paclitaxel 631 Radiotherapy 574 Gemcitabine 572 Biopsy 529 Bevacizumab 476 Dexamethasone 440 fludarabine 407 Docetaxel 378 venetoclax 370 Oxaliplatin 365 Capecitabine 358 Fluorouracil 355 atezolizumab 344 durvalumab 334 Rituximab 333 Doxorubicin 317 Radiosurgery 309 Pemetrexed 306 Drug Therapy 303 Ipilimumab 294 Standard of Care 293 Etoposide 285 Radiation 281

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × darlin protein, Dictyostelium × 1 year × Clear all

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡